- Grants since 2016
- 489
- Awarded, last 5 years (where amounts are published)
- €181.1M
- Funded works, last 5 years
- 3 159
- Funded works, all time
- 5 628
Grants
2018–2022 · research · RIA
Combined HIV African Prevention Study: On demand Truvada and F/TAF Pre-exposure and Post exposure prophylaxis to protect adolescents from HIV
Julie Fox · King's College London
2018–2022 · research · CSA
Biomedical Ethics and Regulatory Capacity Building Partnership for Portuguese-Speaking African Countries
Maria Do Céu Patrão Neves · Ordem dos Farmaceuticos
2018–2023 · research · RIA
Fast and reliable easy-to-use-diagnostics for eliminating Bilharzia in young children and mothers
Govert Van Dam · Academisch Ziekenhuis Leiden (lumc)
2018–2022 · research · RIA
PREVENTION OF MOTHER-TO-CHILD TRANSMISSION OF HIV-1: PROGRAM EVALUATION AND INNOVATIVE RESCUE INTERVENTION INTEGRATED IN THE EXPANDED PROGRAM OF IMMUNIZATION
Philippe Van De Perre · Institut Immunologie, Inflammation, Infectiologie Et Microbiologie (i3m) Inserm
2018–2022 · research · CSA
Competence-based Fellowship for African Medicines Reviewers and Regulatory Science Professionals
Tariro Makamure-Sithole · Medicines Control Authority Of Zimbabwe (mcaz)
2018–2024 · research · RIA
A multicenter Phase III double-blind, randomized, controlled study to evaluate the efficacy and safety of VPM1002 in comparison to BCG.
Leander Grode · Serum Life Science Europe Gmbh
2018–2020 · fellowship · TMA
TMA2016IF-Liyoyo
Alphonce Liyoyo · Kibong'oto Infectious Diseases Hospital (kidh)
2018–2020 · fellowship · TMA
Host-directed therapy: Myeloid derived suppressor cell ablation by phosphodiesterase inhibitor
Nelita Du Plessis · Stellenbosch University
2018–2023 · research · RIA
Non-Inferiority of Fractional Doses Trial for Yellow Fever Vaccine
Philip Bejon · University of Oxford
2018–2021 · fellowship · TMA
Impact of standard antiretroviral therapy on the pharmacokinetic profile and placental penetration of piperaquine administered as dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria among HIV-infected pregnant women in Malawi
Clifford George Banda · Kamuzu University of Health Sciences
2018–2021 · fellowship · TMA
Vaccines and Medicines utilisation and safety monitoring system in a Health and Demographic Surveillance System, Uganda
Dan Kajungu · Makerere University
2018–2021 · fellowship · TMA
Safety and Efficacy of Intermittent Presumptive Treatment with Sulfadoxine-Pyrimethamine using Rapid Diagnostic Test Screening And Treatment at First Antenatal Care Visit
Jean-Bertin Bukasa Kabuya · Tropical Diseases Research Centre
2018–2023 · research · RIA
Rapid and accurate diagnosis of paediatric TB
Norbert Heinrich · Ludwig-maximilians-universitaet Muenchen (lmu)
2018–2022 · research · CSA
Strengthening research ethics review and oversight in Kenya
Walter Jaoko · University of Nairobi
2018–2021 · research · CSA
AFRica Ethics Excellence NETwork
Virginie Pirard · Institut Pasteur
2018–2021 · research · CSA
Building Capacity for Research Ethics and Regulation in Zambia
Godfrey Biemba · National Health Research Authority (nhra)
2018–2021 · fellowship · TMA
Immunogenicity to cholera vaccine within a population at risk in Zambia: mapping the kinetics of immune responses over time
Caroline Cleopatra Chisenga · Centre for Infectious Disease Research in Zambia
2018–2023 · research · CSA
PhArmaco Vigilance Africa
Frank Cobelens · Stichting Amsterdam Institute For Global Health And Development (aighd)
2018–2024 · research · RIA
Childrens Oxygen Administration Strategies Trial-Nutrition
Kathryn Maitland · Imperial College London
2018–2021 · fellowship · TMA
Identification of host regulators of tissue fibroproliferative pathology in schistosomiasis-diseased children in Africa
Justin Komguep Nono · University of Cape Town
2018–2023 · fellowship · TMA
Pharmacogenomics Research And Clinical Excellence in the Treatment of Infectious Diseases in African Populations
Collen Masimirembwa · African Institute Of Biomedical Science And Technology (private) Limited (aibst)
2018–2022 · fellowship · TMA
Evaluating the response to 4 and 6 month treatment of pulmonary tuberculosis by 18F-FDG PET/CT lung imaging.
Stephanus Malherbe · Stellenbosch University
2017–2019 · fellowship · TMA
EDCTP-TDR TMA 2015 - KAKOLWA
Mwaka Kakolwa · Ifakara Health Institute Trust (ihi)
2017–2026 · research · TRIA
PanACEA, a drug development programme to shorten and simplify treatment of tuberculosis
Jodie Schildkraut · Stichting Katholieke Universiteit- Radboudumc (rumc)
2017–2020 · research · EDCTP
Coast to Coast: Transcontinental Ethics Partnership
Jonas Lexow · London School of Hygiene & Tropical Medicine
2017–2020 · fellowship · TMA
Cluster randomized community-based trial of annual versus biannual single-dose Ivermectin plus Albendazole against Wuchereria bancrofti infection in human and mosquito populations
Dziedzom De Souza · Noguchi Memorial Institute for Medical Research
2017–2021 · fellowship · TMA
Urinary Cytokine ELISA: A tool for Assessing Urinary Tract Pathology in Schistosoma haematobium infections
Humphrey Kariuki Njaanake · University of Nairobi
2017–2019 · fellowship · TMA
Evaluation of Treatment Response, Drug Resistance and HIV-1 Variability among Adolescents on First- and Second-Line Antiretroviral Therapy in Cameroon: The READY-Study
Joseph Fokam · International Reference Centre Chantal Biya (circb)
2017–2020 · fellowship · TMA
Optimising linezolid use for drug-resistant tuberculosis in South Africa: the effects of linezolid exposure on toxicity, treatment response, and linezolid resistance
Sean Wasserman · University of Cape Town
2017–2020 · research · EDCTP
Renforcement de l'Ethique des Essais Cliniques en Afrique de l'Ouest (REECAO)
Karim Traoré · Ministère De La Santé Et Du Développement Social - Mali
2017–2020 · fellowship · TMA
Biomarker profile predicting unsuccessful treatment response in patients with MDR-TB
Ali Esmail · The University Of Cape Town Lung Institute (pty) Ltd
2017–2025 · research · RIA
African coaLition for Epidemic Research, Response and Training
Peter Horby · University of Oxford
2017–2022 · fellowship · TMA
Harnessing parasite diversity and naturally acquired protective immunity against Plasmodium falciparum malaria for the development of highly effective vaccines
Faith Osier · Kenya Medical Research Institute
2017–2020 · fellowship · TMA
Effect of reminder cues and tailored feedback on adherence to antiretroviral drug treatment among HIV positive individuals in the Kilimanjaro region, Tanzania
Ilse Marion Sumari-De Boer · The Good Samaritan Foundation (kilimanjaro Christian Medical Centre Gsf Kcmc)
2017–2020 · fellowship · TMA
Rapid detection of Mycobaterium ulcerans infection by recombinase polymerase amplification
Michael Frimpong · Kwame Nkrumah University of Science and Technology
2017–2019 · research · CSA
Improved Governance and Research Capacities in Diagnostics for Infections Diseases of the Liberian Medicines and Health Products Regulatory Authority
Alfredo Mayor Aparicio · Fundación Privada Instituto De Salud Global Barcelona (isglobal)
2017–2020 · fellowship · TMA
The impact of pulmonary tuberculosis and other lower respiratory tract pathogens on lung function in young South African children
Marieke Van Der Zalm · Stellenbosch University
2017–2019 · research · EDCTP
Consortium for Clinical Research Regulation and Ethics Capacity Development in Uganda
Winfred Badanga Nazziwa · Uganda National Council for Science and Technology
2017–2021 · research · TRIA
High Dose AMBISOME on a Fluconazole Backbone for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: A Randomised Controlled Non-inferiority Trial
Joseph Jarvis · London School of Hygiene & Tropical Medicine
2017–2019 · research · EDCTP
Developing LMHRA capacity to effectively exercise its regulatory mandate in clinical trials and health research in Liberia
David Sumo · Liberia Medicines And Health Products Regulatory Authority